Seeff L B, Miller R N, Rabkin C S, Buskell-Bales Z, Straley-Eason K D, Smoak B L, Johnson L D, Lee S R, Kaplan E L
Veterans Affairs Medical Center, Washington, DC 20422, USA.
Ann Intern Med. 2000 Jan 18;132(2):105-11. doi: 10.7326/0003-4819-132-2-200001180-00003.
The sequelae during the first two decades after acute hepatitis C virus (HCV) infection have been well studied, but the outcome thereafter is unknown.
To conduct an extended study of the natural history of HCV infection by using archived serum specimens originally collected between 1948 and 1954.
Retrospective cohort study.
A university, a Veterans Affairs medical center, and a medical follow-up agency that had access to the serum specimens and accompanying demographic and medical records.
8568 military recruits who were evaluated for group A streptococcal infection and acute rheumatic fever between 1948 and 1954. Blood samples were taken from the recruits and, after testing, were stored frozen for almost 45 years.
The presence of antibodies to HCV was determined by enzyme-linked immunoassay, supplementary recombinant immunoblot assay, and polymerase chain reaction for HCV RNA. Morbidity and mortality were also assessed.
Of 8568 persons, 17 (0.2%) had positive results on enzyme-linked immunosorbent assay and recombinant immunoblot assay. The rate was 1.8% among the African-American persons and 0.1% among the white persons in the total sample (relative risk, 25.9 [95% CI, 8.4 to 80.0]). During the 45-year follow-up, liver disease occurred in 2 of the 17 HCV-positive persons (11.8%) and 205 of the 8551 HCV-negative persons (2.4%) (ethnicity-adjusted relative risk, 3.56 [CI, 0.94 to 13.52]). Seven of the 17 HCV-positive persons (41 %) and 2226 of the 8551 HCV-negative persons (26%) had died by December 1996 (ethnicity-adjusted relative risk, 1.48 [CI, 0.8 to 2.6]). Of persons who were HCV-positive, 1 (5.9%) died of liver disease 42 years after the original phlebotomy, 5 (29%) died of non-liver-related disease a median of 37 years after the original phlebotomy, and 1 (5.9%) died of unknown causes. One hundred nineteen HCV-negative persons (1.4%) died of liver disease.
The rate of HCV infection from 1948 to 1954 among a sample of military recruits parallels that among present-day military recruits and volunteer blood donors. During 45 years of follow-up, HCV-positive persons had low liver-related morbidity and mortality rates. This suggests that healthy HCV-positive persons may be at less risk for progressive liver disease than is currently thought.
急性丙型肝炎病毒(HCV)感染后头二十年的后遗症已得到充分研究,但此后的结局尚不清楚。
通过使用1948年至1954年期间最初收集的存档血清标本,对HCV感染的自然史进行扩展研究。
回顾性队列研究。
一所大学、一家退伍军人事务医疗中心以及一家能够获取血清标本及相关人口统计学和医疗记录的医疗随访机构。
1948年至1954年期间接受A组链球菌感染和急性风湿热评估的8568名新兵。从新兵身上采集血样,检测后冷冻保存近45年。
通过酶联免疫吸附测定、补充重组免疫印迹测定和HCV RNA聚合酶链反应确定HCV抗体的存在。还评估了发病率和死亡率。
在8568人中,17人(0.2%)酶联免疫吸附测定和重组免疫印迹测定结果呈阳性。在整个样本中,非裔美国人中的阳性率为1.8%,白人中的阳性率为0.1%(相对危险度,25.9[95%可信区间,8.4至80.0])。在45年的随访期间,17名HCV阳性者中有2人(11.8%)发生肝病,8551名HCV阴性者中有205人(2.4%)发生肝病(经种族调整的相对危险度,3.56[可信区间,0.94至13.52])。截至1996年12月,17名HCV阳性者中有7人(41%)死亡,8551名HCV阴性者中有2226人(26%)死亡(经种族调整的相对危险度,1.48[可信区间,0.8至2.6])。在HCV阳性者中,1人(5.9%)在首次采血42年后死于肝病,5人(29%)在首次采血中位数37年后死于非肝病相关疾病,1人(5.9%)死因不明。119名HCV阴性者(1.4%)死于肝病。
1948年至1954年期间一组新兵中的HCV感染率与当今新兵和志愿献血者中的感染率相当。在45年的随访期间,HCV阳性者的肝病相关发病率和死亡率较低。这表明健康的HCV阳性者发生进行性肝病的风险可能比目前认为的要低。